home / stock / gnbt / gnbt news

GNBT News and Press, Generex Biotechnology From 05/02/19

Stock Information
Company Name: Generex Biotechnology
Stock Symbol: GNBT
Market: OTC
Website: generex.com
Menu
GNBT GNBT Quote GNBT Short GNBT News GNBT Articles GNBT Message Board
Get GNBT Alerts

News, Short Squeeze, Breakout and More Instantly...
GNBT - Generex Biotechnology Subsidiary NuGenerex Diagnostics Announces Sales for its Rapid Point-of-Care Malaria Diagnostic Test Kit

MIRAMAR, Fla., May 02, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is pleased to announce that their wholly-owned subsidiary NuGenerex Diagnostics LLC, ( www.nugenerexdiangostics.com ) has filled ...
GNBT - Generex Biotechnology Announces Organizational Roadmap & Investor Conference Call: Update on Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans

MIRAMAR, Florida , April 29, 2019 /PRNewswire/ -- Launch of ExcellagenÒ for Wound Healing by subsidiary Olaregen Therapeutix Pending completion of acquisitions: Pantheon Medical, MediSource Partners, and Fuse Medical, Financing initiatives  S1 Filing Applicati...

GNBT - Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors Prestigious Diabetic Limb Salvage Conference in Washington D.C.

Inventor Dr. Lois Chandler, PhD Presents Excellagen® Clinical Trial Data Demonstrating Rapid Healing of Diabetic Neuropathic Foot Ulcers MIRAMAR, FL, April 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www...

GNBT - Kali-Extracts To Present Cannabis Treatment R&D For $170 Million In Pharmaceutical Market Opportunity On April 17th

DALLAS, April 09, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced an online presentation scheduled next week for Wednesday, April 17 th , where management will provide details on its pa...
GNBT - Generex Biotechnology Corporation Appoints Mark J. Prioletti to the Board of Directors

Sales & Marketing Executive Brings Global Expertise in Global Channel Marketing MIRAMAR, FL, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is pr...

GNBT - Generex Addresses Shareholder Concern Over 8-K and Quarterly Filing

MIRAMAR, FL, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex would like to clarify the discussions surrounding the filed 10-Q ending the period of January 31, 2019, or the second quarter, filed on March 25, 2019, and its subsequent non-reliance 8-K filed on March 28, 2019. ...

GNBT - Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million

Generex and Veneto Holdings Re-Negotiate Acquisition from a $35 Million Total Consideration to a $21 Million Stock-Only Transaction at $2.50 Per Share to Satisfy Generex’ Obligations MIRAMAR, FL, March 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnolo...
GNBT - Generex Biotechnology Partner Olaregen Therapeutix, Inc. Selected to Present a Formal Poster Session at Prestigious Diabetic Limb Salvage Meeting

Excellagen Clinical Trial Analysis: Rapid Healing of Diabetic Neuropathic Foot Ulcers Presentation on Friday Evening April 5, 2019 at the JW Marriott Hotel in Washington, DC MIRAMAR, FL, March 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnol...

GNBT - USMJ and PURA Update Dividend Distribution Plans With PJET and NOUV To Include New Developments With WCVC and KALY

DALLAS, March 22, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) and Puration Inc. (USOTC: PURA) (“PURA”) today published an update on the progress the two companies are making toward their respective pla...

GNBT - KALY Phase One Cannabis Extract COPD Research To Be Published This Friday, March 22, 2019

DALLAS, March 20, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE --   Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the company plans to publish its phase one research on the pilot treatment of Chronic Obstructive Pulmonary...
Previous 10 Next 10